Biocon Limited
BIOCON
Rankning i aktier
#3532
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Aktiekurs
$3.50
Marknadsvärde
$4.78B
Förändring (1 dag)
-4.99%
Förändring (1 år)
-15.93%
Land
IN
Handel Biocon Limited (BIOCON)
Kategori
Healthcare
Aktiekurshistorik för Biocon Limited (BIOCON)
Högsta slutkurs: $3.87 den 2026-10-01
Lägsta slutkurs: $1.16 den 2004-04-01
Lägsta slutkurs: $1.16 den 2004-04-01
Aktiekurshistorik för Biocon Limited från 2004 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -0.48% |
| 2025 | 3.10% |
| 2024 | 43.03% |
| 2023 | -9.84% |
| 2022 | -32.34% |
| 2021 | -21.74% |
| 2020 | 51.69% |
| 2019 | -7.50% |
| 2018 | 8.33% |
| 2017 | 76.96% |
| 2016 | 90.65% |
| 2015 | 2.58% |
| 2014 | 4.05% |
| 2013 | 29.61% |
| 2012 | -4.48% |
| 2011 | -38.93% |
| 2010 | 49.26% |
| 2009 | 165.57% |
| 2008 | -69.07% |
| 2007 | 80.35% |
| 2006 | -25.48% |
| 2005 | -5.27% |
| 2004 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.70 | 7.84% |
CH
|
